Users of smoking-cessation products such as GlaxoSmithKline Plc's Nicorette gum will be able to use the products longer and in combination with other therapies under new U.S. Food and Drug Administration labeling rules.
http://washpost.bloomberg.com/Story?docId=1376-MKKW5U6JTSFF01-2SKK8D784NTG71J8BVRRNEQL37
http://washpost.bloomberg.com/Story?docId=1376-MKKW5U6JTSFF01-2SKK8D784NTG71J8BVRRNEQL37
No comments:
Post a Comment